Pascal Deschatelets

(Dr. Pascal Deschatelets Ph.D.)

Currently holds a position at Apellis Pharmaceuticals Inc

Positions
Position Company Period
Co-Founder, Chief Operating Officer Apellis Pharmaceuticals Inc Jan. 1, 2016 -
Chief Operating Officer Apellis Pharmaceuticals Inc Sept. 1, 2009 - Jan. 1, 2016
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-03-11 2024-03-08
PS Planned sale
100 -0.0%
63.35
6,335 USD 		100 -0.0% 63.35 6,335 USD
2024-03-11 2024-03-08
PS Planned sale
26,257 -2.3%
62.69
1,646,041 USD 		26,257 -2.3% 62.69 1,646,041 USD
2024-03-11 2024-03-08
PS Planned sale
42,750 -3.6%
61.88
2,645,173 USD 		42,750 -3.6% 61.88 2,645,173 USD
2024-02-13 2024-02-12
S Sale
1,148 -0.1%
67.77
77,796 USD 		1,148 -0.1% 67.77 77,796 USD
2024-01-31 2024-01-29
S Sale
874 -0.1%
64.14
56,057 USD 		874 -0.1% 64.14 56,057 USD
2024-01-23 2024-01-22
S Sale
3,913 -0.3%
65.00
254,329 USD 		3,913 -0.3% 65.00 254,329 USD
2024-01-17 2024-01-16
S Sale
1,632 -0.1%
66.81
109,032 USD 		1,632 -0.1% 66.81 109,032 USD
2023-10-10 2023-10-09
PS Planned sale
12,000 -1.1%
40.38
484,560 USD 		12,000 -1.1% 40.38 484,560 USD
2023-09-11 2023-09-08
S Sale
12,000 -1.1%
42.87
514,440 USD 		12,000 -1.1% 42.87 514,440 USD
2023-08-09 2023-08-08
PS Planned sale
12,000 -1.1%
23.66
283,920 USD 		12,000 -1.1% 23.66 283,920 USD
2023-07-11 2023-07-10
PS Planned sale
12,000 -1.1%
84.55
1,014,600 USD 		12,000 -1.1% 84.55 1,014,600 USD
2023-06-09 2023-06-08
PS Planned sale
12,000 -1.1%
91.35
1,096,200 USD 		12,000 -1.1% 91.35 1,096,200 USD
2023-05-09 2023-05-08
PS Planned sale
12,000 -1.1%
92.39
1,108,680 USD 		12,000 -1.1% 92.39 1,108,680 USD
2023-04-11 2023-04-10
PS Planned sale
12,000 -1.2%
78.21
938,520 USD 		12,000 -1.2% 78.21 938,520 USD
2023-02-10 2023-02-08
PS Planned sale
12,000 -1.2%
54.45
653,400 USD 		12,000 -1.2% 54.45 653,400 USD
2023-01-10 2023-01-09
PS Planned sale
12,000 -1.2%
46.08
552,960 USD 		12,000 -1.2% 46.08 552,960 USD
2022-12-12 2022-12-08
PS Planned sale
12,000 -1.2%
47.50
570,000 USD 		12,000 -1.2% 47.50 570,000 USD
2022-09-12 2022-09-08
PS Planned sale
12,000 -1.2%
63.98
767,760 USD 		12,000 -1.2% 63.98 767,760 USD
2022-08-09 2022-08-08
PS Planned sale
12,000 -1.3%
62.50
750,000 USD 		12,000 -1.3% 62.50 750,000 USD
2022-06-09 2022-06-08
PS Planned sale
12,000 -1.3%
44.09
529,080 USD 		12,000 -1.3% 44.09 529,080 USD
2022-05-02 2022-04-29
PS Planned sale
4,000 -0.4%
44.43
177,720 USD 		4,000 -0.4% 44.43 177,720 USD
2021-06-25 2021-06-24
PS Planned sale
6,250 -0.7%
65.61
410,063 USD 		6,250 -0.7% 65.61 410,063 USD
2021-05-25 2021-05-24
PS Planned sale
6,250 -0.7%
47.40
296,250 USD 		6,250 -0.7% 47.40 296,250 USD
2021-04-26 2021-04-23
PS Planned sale
6,250 -0.7%
46.13
288,313 USD 		6,250 -0.7% 46.13 288,313 USD
2021-03-11 2021-03-10
S Sale
6,250 -0.7%
50.74
317,125 USD 		6,250 -0.7% 50.74 317,125 USD
2020-02-14 2020-02-13
S Sale
55,398 -5.2%
40.98
2,270,155 USD 		55,398 -5.2% 40.98 2,270,155 USD
2020-02-14 2020-02-12
S Sale
52,075 -5.2%
42.80
2,228,966 USD 		52,075 -5.2% 42.80 2,228,966 USD
2019-09-26 2019-09-25
PS Planned sale
1,010 -0.1%
25.64
25,897 USD 		1,010 -0.1% 25.64 25,897 USD
2019-09-26 2019-09-25
PS Planned sale
20,531 -2.3%
25.24
518,161 USD 		20,531 -2.3% 25.24 518,161 USD
2019-09-25 2019-09-24
PS Planned sale
1,295 -0.1%
24.96
32,321 USD 		1,295 -0.1% 24.96 32,321 USD
2019-09-25 2019-09-24
PS Planned sale
20,307 -2.2%
24.56
498,760 USD 		20,307 -2.2% 24.56 498,760 USD
2019-09-25 2019-09-23
PS Planned sale
100 -0.0%
25.53
2,553 USD 		100 -0.0% 25.53 2,553 USD
2019-09-25 2019-09-23
PS Planned sale
20,758 -2.2%
25.07
520,362 USD 		20,758 -2.2% 25.07 520,362 USD